Invesco’s Kestra Medical Technologies KMTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$376K Buy
14,786
+2,565
+21% +$53.7K ﹤0.01% 3357
2026
Q1
$244K Buy
12,221
+3,207
+36% +$75.6K ﹤0.01% 3415
2025
Q4
$239K Buy
+9,014
New +$232K ﹤0.01% 3467
2025
Q3
Sell
-212,166
Closed -$3.52M 3872
2025
Q2
$3.52M Buy
212,166
+12,166
+6% +$266K ﹤0.01% 2355
2025
Q1
$4.98M Buy
+200,000
New +$4.6M ﹤0.01% 2151

Other funds holding KMTS

Invesco's KMTS Position: Q2 2026 in Review

Invesco increased its Kestra Medical Technologies (KMTS) stake by 21% in Q2 2026, buying an estimated $53.7K and bringing the position to 14,786 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #3357.

Invesco first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.98M in Q1 2025. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Invesco held 14,786 shares of Kestra Medical Technologies worth $376K as of Q2 2026.
  • Invesco bought 2,565 Kestra Medical Technologies shares in Q2 2026, an estimated $53.7K.
  • Kestra Medical Technologies made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3357 holding.
  • Invesco first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • Invesco's Kestra Medical Technologies position peaked at $4.98M in Q1 2025.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.